Drugs with this side effect as MedDRA Preferred Term
- 2-hydroxysuccinaldehyde
- Anaemia: postmarketing
- Secondary anemia
- 4-PBA
- 4-methylpyrazole
- 5-ASA
- 5-FU
- 5-aminolevulinic acid
- 5-aza-2'-deoxycytidine
- 5-azacytidine
- Anaemia: very common, 2.3% - 69.5%
- Anaemia NOS aggravated: 5.43% - 5.45%
- 5-fluorocytosine
- 6-mercaptopurine
- 68Ga
- A77 1726
- APAs
- Anidulafungin
- BCNU
- BPTI
- Benicar-HCT
- Bivalirudin
- CAS 76095-16-4
- CAS 76420-72-9
- CGP 19835A
- Cancidas
- Anaemia: uncommon, 0% - 11%
- Carfilzomib
- D-penicillamine
- EDTA
- FAMP
- FK463
- Anaemia: 2.5% - 51.2%
- Anaemia NOS aggravated: 2% - 4.95%
- FdUrd
- Fe(III
- Forteo
- Ge-132
- Glat copolymer
- Goserelin
- Histrelin
- ICI 182,780
- K779
- Anaemia: postmarketing, 0% - 35%
- L-Dmp
- LMWH
- LY146032
- Anaemia: postmarketing, common, 2.1% - 15.5%
- Leuprorelin
- Lisinopril
- Anaemia: very rare, postmarketing
- Meropenem anhydrous
- N-carbamylglutamate
- NSC 352122
- Nuvocid
- Octreotide
- PCI-32765
- PGE1
- Photofrin
- Photofrin II
- Promacta
- Refludan
- Revasc
- Romidepsin
- SOM230
- SU5416
- Signifor
- TMC435
- TR-700
- Triptorelin
- UDCA
- VACV
- Vancocine
- ZnCl2
- abacavir
- abacavir-lamivudine
- abiraterone
- acamprosate
- acetaminophen
- acetohydroxamic acid
- actinomycin D
- acyclovir
- adefovir dipivoxil
- alendronate
- aliskiren
- allopurinol
- alpha-methyl-p-tyrosine
- alvimopan
- ambrisentan
- amikacin
- aminoglutethimide
- amoxicillin
- amphotericin B
- ampicillin
- amsacrine
- anagrelide
- anastrozole
- anthracycline
- apixaban
- Anaemia: common, 2.58% - 3.01%
- aprepitant
- aripiprazole
- arsenic
- arsenic trioxide
- asenapine
- aspirin
- atorvastatin
- atovaquone
- auranofin
- Anaemia: postmarketing, 1.6% - 3.1%
- axitinib
- azathioprine
- azithromycin
- aztreonam
- baclofen
- balsalazide
- belinostat
- bendamustine
- betaxolol
- bexarotene
- bezafibrate
- bicalutamide
- bleomycin hydrochloride
- boceprevir
- Anaemia: very common, 20% - 30%
- bortezomib
- bosentan
- Anaemia: postmarketing, common, 8%
- bosutinib
- bromcresol green
- budesonide
- bupivacaine
- bupropion
- Anaemia: postmarketing, rare
- busulfan
- cabazitaxel
- candesartan
- candesartan cilexetil
- capecitabine
- captopril
- carbamazepine
- carbenicillin
- carbidopa
- carboplatin
- carnitine
- carvedilol
- cefazolin
- cefepime
- cefoxitin
- cefpodoxime
- ceftaroline
- ceftizoxime
- ceftobiprole
- ceftriaxone
- celecoxib
- cerivastatin
- cevimeline
- chlorambucil
- cidofovir
- Anaemia: postmarketing, 24.3%
- cilazapril
- cilostazol
- cinacalcet
- ciprofloxacin
- Anaemia: postmarketing, rare
- cisplatin
- citalopram
- Anaemia: postmarketing, infrequent, uncommon
- cladribine
- clarithromycin
- clindamycin
- clobazam
- clodronate
- clofarabine
- clofazimine
- clomipramine
- clonazepam
- clopidogrel
- Anaemia: very rare, postmarketing
- clozapine
- colchicine
- colestyramine
- conivaptan
- copolymer 1
- copper
- crizotinib
- cyclophosphamide
- cyproterone
- cyproterone acetate
- cysteamine
- cytarabine
- d-telaprevir
- dabigatran etexilate
- dabrafenib
- dalbavancin
- dalteparin
- dantrolene
- darunavir
- dasatinib
- deferasirox
- Anaemia: postmarketing
- Anaemia NOS aggravated
- degarelix
- delamanid
- delavirdine
- deprenyl
- dexmedetomidine
- Anaemia: postmarketing, 2% - 3%
- dexrazoxane
- diatrizoate
- diazepam
- diclofenac
- Anaemia: very rare
- Secondary anemia
- dicloxacillin
- didanosine
- dipyridamole
- docetaxel
- dolasetron
- donepezil
- Anaemia: infrequent, frequent
- doripenem
- doxepin
- doxercalciferol
- doxorubicin
- Anaemia: uncommon, very common, 0% - 72.2%
- doxycycline
- duloxetine
- efavirenz
- eletriptan
- eltrombopag
- emtricitabine
- Anaemia: postmarketing, uncommon, 7% - 9.5%
- eplerenone
- eribulin
- ertapenem
- eslicarbazepine acetate
- esomeprazole magnesium
- estramustine phosphate
- etidronate
- etodolac
- etoposide
- etoposide phosphate
- etoricoxib
- etravirine
- everolimus
- Anaemia: common, very common, 0% - 61%
- ezetimibe
- famciclovir
- famotidine
- febuxostat
- felbamate
- felodipine
- fenofibrate
- fenofibric acid
- fentanyl
- Anaemia: common, 9.09% - 31.6%
- fidaxomicin
- flucloxacillin
- fluconazole
- fludarabine
- fluoxetine
- flurbiprofen
- flutamide
- fluvoxamine
- Anaemia: rare, infrequent
- fondaparinux
- Anaemia: uncommon, common, 0.272% - 19.6%
- fosaprepitant
- fosaprepitant dimeglumine
- foscarnet
- fosinopril
- fosinoprilat
- fosphenytoin
- fotemustine
- furosemide
- fusidic acid
- gabapentin
- Anaemia: postmarketing, infrequent
- gadobenate dimeglumine
- galantamine
- ganciclovir
- gefitinib
- gemcitabine
- Anaemia: very common, 0% - 86%
- gemfibrozil
- gemifloxacin
- gentamicin
- glibenclamide
- gliclazide
- glimepiride
- granisetron
- guanidinium
- haloperidol
- hetastarch
- hexamethylmelamine
- histamine
- hydralazine
- hydrochlorothiazide
- hydroxybutyrate
- hydroxychloroquine
- hydroxyurea
- ibandronate
- ibuprofen
- icodextrin
- idarubicin
- ifosfamide
- iloperidone
- imatinib
- Anaemia: postmarketing, very common, 0% - 42%
- indacaterol
- indapamide
- indinavir
- indomethacin
- iodide
- irbesartan
- irbesartan-hydrochlorothiazide
- irinotecan
- isosorbide-5-mononitrate
- isradipine
- ivermectin
- ixabepilone
- ketoprofen
- ketorolac
- ketorolac tromethamine
- lacosamide
- lamivudine
- Anaemia: postmarketing, uncommon, 1% - 4%
- lamotrigine
- Anaemia: rare, infrequent
- lanreotide
- lansoprazole
- lapatinib
- lasofoxifene
- leflunomide
- lenalidomide
- Anaemia: postmarketing, common, 6.1% - 31.4%
- lercanidipine
- leuprorelin acetate
- levodopa/carbidopa
- levonorgestrel
- linezolid
- Anaemia: postmarketing, 0% - 7.1%
- lithium carbonate
- lomefloxacin
- lomitapide
- losartan
- Anaemia: postmarketing, 14%
- lurasidone
- mTHPC
- macitentan
- maraviroc
- medroxyprogesterone
- medroxyprogesterone acetate
- mefenamic acid
- megestrol
- meloxicam
- melphalan
- memantine
- mephenytoin
- meropenem
- mesna
- methotrexate
- methylphenidate
- Anaemia: very rare, postmarketing
- metolazone
- mianserin
- miconazole
- mirtazapine
- Anaemia: postmarketing, rare
- misoprostol
- mitomycin C
- mitotane
- mitoxantrone
- modafinil
- morphine
- moxifloxacin
- mycophenolate mofetil
- mycophenolic acid
- nabilone
- nabumetone
- Anaemia: postmarketing, 0.5%
- naproxen
- naratriptan
- nefazodone
- nelarabine
- nelfinavir
- nevirapine
- Anaemia: postmarketing, uncommon, 7% - 7.3%
- nifedipine
- nilotinib
- Anaemia: common, 4% - 27%
- nilutamide
- nimodipine
- nisoldipine
- nitazoxanide
- nitrofurantoin
- nizatidine
- ofatumumab
- ofloxacin
- olanzapine
- olmesartan
- olsalazine
- omeprazole
- oseltamivir
- oxaliplatin
- Anaemia: very common, 0.1% - 85.2%
- oxaprozin
- oxycodone
- paclitaxel
- Anaemia: uncommon, very common, 4% - 97%
- Anemic
- paliperidone
- palonosetron
- pamidronate
- Anaemia: postmarketing, common, 0% - 47.8%
- pantoprazole
- paricalcitol
- paroxetine
- Anaemia: infrequent, uncommon
- pazopanib
- pemetrexed
- penciclovir
- pentamidine
- pentastarch
- pentosan polysulfate
- pentostatin
- pentoxifylline
- pergolide
- perindopril
- perindopril erbumine
- perindoprilat
- phenylbutyric acid
- phenytoin
- pimozide
- pioglitazone
- piperacillin
- piroxicam
- pixantrone
- pomalidomide
- ponatinib
- posaconazole
- Anaemia: 1.91% - 14.2%
- Anaemia NOS aggravated
- pralatrexate
- pramipexole
- prasugrel
- pravastatin
- prednisone
- pregabalin
- prilocaine
- primidone
- probenecid
- procarbazine
- progesterone
- propafenone
- prostacyclin
- quetiapine
- rabeprazole
- radium
- raltegravir
- raltitrexed
- ranitidine
- rapamycin
- Anaemia: very common, 21% - 37%
- rasagiline
- rasburicase
- reboxetine
- regorafenib
- remifentanil
- retinoic acid
- ribavirin
- Anaemia: common, very common, 0.6-0.8% - 35%
- rifabutin
- rifampicin
- rifapentine
- rifaximin
- riluzole
- riociguat
- risedronate
- risperidone
- Anaemia: infrequent, 0.1% - 1%
- ritonavir
- rivaroxaban
- rivastigmine
- ropinirole
- ropivacaine
- rosiglitazone
- rufinamide
- ruxolitinib
- Anaemia: very common, 11% - 96.1%
- salmon calcitonin acetate
- samarium
- saquinavir
- sertraline
- sibutramine
- sildenafil
- simvastatin
- sitaxsentan
- sodium cromoglycate
- sodium ferric gluconate
- sofosbuvir
- Anaemia: common, very common, 0% - 21%
- sorafenib
- Anaemia: postmarketing, common
- stavudine
- Anaemia: postmarketing, rare
- streptozotocin
- sulfasalazine
- sulindac
- sumatriptan
- sunitinib
- tacrolimus
- Anaemia: common, 1% - 50%
- tamoxifen
- telavancin
- telithromycin
- telmisartan
- Anaemia: postmarketing, rare, uncommon
- temozolomide
- Anaemia: uncommon, common, 1% - 2%
- temsirolimus
- teniposide
- tenofovir disoproxil fumarate
- tenoxicam
- terbinafine
- testosterone
- Anaemia: postmarketing, 2.47% - 2.5%
- thalidomide
- thioridazine
- thiotepa
- tiagabine
- tiaprofenic acid
- tigecycline
- tiopronin
- tipranavir
- Anaemia: uncommon, 0% - 2.3%
- tizanidine
- tobramycin
- tofacitinib
- tolcapone
- topiramate
- Anaemia: frequent, 0.8% - 3%
- topotecan
- Anaemia: very common, 1.9% - 98%
- trabectedin
- tramadol
- Anaemia: postmarketing, uncommon
- trametinib
- trandolapril
- tranexamic acid
- tranylcypromine
- trazodone
- treprostinil
- trimetrexate
- troglitazone
- trovafloxacin
- v 1784
- Anaemia: postmarketing, uncommon, common
- valdecoxib
- valganciclovir
- valproate
- valrubicin
- varenicline
- venlafaxine
- verteporfin
- vigabatrin
- vinblastine
- vincristine
- vinflunine
- vinorelbine
- vitamin D2
- vorapaxar
- voriconazole
- Anaemia: common, 0% - 2.7%
- vorinostat
- warfarin
- zalcitabine
- zaleplon
- zidovudine
- zidovudine/lamivudine
- ziprasidone
- zoledronic acid
- Anaemia: postmarketing, common, 4.4% - 22%
- zolpidem
- zonisamide
- zopiclone
|
Drugs with this indication
|